The activity of calpains in lymphocytes is glucose-dependent and is decreased in diabetic patients

Blood Cells, Molecules, and Diseases

Volumn 40, Issue 3, 2008, Pages 414-419

  Díaz Villaseñor, Andrea ^a   Hiriart, Marcia ^a   Cebrián, Mariano E ^b   Zacarías Castillo, Rogelio ^c   Ostrosky Wegman, Patricia ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

^c HOSPITAL GENERAL DR MANUEL GEA GONZÁLEZ   (Mexico)

Author keywords

Calpains; Glucose; Lymphocytes; Type 2 diabetes mellitus

Indexed keywords

CALPAIN; CALPAIN 10; GLUCOSE; MESSENGER RNA;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; ENZYME ACTIVITY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; LEUKOCYTE; LYMPHOCYTE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BLOTTING; PROTEIN EXPRESSION;

ADULT; BLOOD GLUCOSE; CALPAIN; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; PROTEIN ISOFORMS; RNA, MESSENGER;

EID: 41949115626     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2007.08.009     Document Type: Article

References (40)

1. Zimmet P., Alberti K.G., and Shaw J. Global and societal implications of the diabetes epidemic. Nature 414 (2001) 782-787
2. ADA. Diagnosis and classification of diabetes mellitus. Diabetes Care 29 Suppl 1 (2006) S43-S48
3. Horikawa Y., Oda N., Cox N.J., Li X., Orho-Melander M., Hara M., Hinokio Y., Lindner T.H., Mashima H., Schwarz P.E., del Bosque-Plata L., Oda Y., Yoshiuchi I., Colilla S., Polonsky K.S., Wei S., Concannon P., Iwasaki N., Schulze J., Baier L.J., Bogardus C., Groop L., Boerwinkle E., Hanis C.L., and Bell G.I. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat. Genet. 26 (2000) 163-175
4. del Bosque-Plata L., Aguilar-Salinas C.A., Tusie-Luna M.T., Ramirez-Jimenez S., Rodriguez-Torres M., Auron-Gomez M., Ramirez E., Velasco-Perez M.L., Ramirez-Silva A., Gomez-Perez F., Hanis C.L., Tsuchiya T., Yoshiuchi I., Cox N.J., and Bell G.I. Association of the calpain-10 gene with type 2 diabetes mellitus in a Mexican population. Mol. Genet. Metab. 81 (2004) 122-126
5. Weedon M.N., Schwarz P.E., Horikawa Y., Iwasaki N., Illig T., Holle R., Rathmann W., Selisko T., Schulze J., Owen K.R., Evans J., Del Bosque-Plata L., Hitman G., Walker M., Levy J.C., Sampson M., Bell G.I., McCarthy M.I., Hattersley A.T., and Frayling T.M. Meta-analysis and a large association study confirm a role for calpain-10 variation in type 2 diabetes susceptibility. Am. J. Hum. Genet. 73 (2003) 1208-1212
6. Marshall C., Hitman G.A., Partridge C.J., Clark A., Ma H., Shearer T.R., and Turner M.D. Evidence that an isoform of calpain-10 is a regulator of exocytosis in pancreatic beta-cells. Mol. Endocrinol. 19 (2005) 213-224
7. Turner M.D., Fulcher F.K., Jones C.V., Smith B.T., Aganna E., Partridge C.J., Hitman G.A., Clark A., and Patel Y.M. Calpain facilitates actin reorganization during glucose-stimulated insulin secretion. Biochem. Biophys. Res. Commun. 352 (2007) 650-655
8. Aganna E., Burrin J.M., Hitman G.A., and Turner M.D. Involvement of calpain and synaptotagmin Ca2+ sensors in hormone secretion from excitable endocrine cells. J. Endocrinol. 190 (2006) R1-R7
9. Ort T., Voronov S., Guo J., Zawalich K., Froehner S.C., Zawalich W., and Solimena M. Dephosphorylation of beta2-syntrophin and Ca2+/mu-calpain-mediated cleavage of ICA512 upon stimulation of insulin secretion. EMBO J. 20 (2001) 4013-4023
10. Zhou Y.P., Sreenan S., Pan C.Y., Currie K.P., Bindokas V.P., Horikawa Y., Lee J.P., Ostrega D., Ahmed N., Baldwin A.C., Cox N.J., Fox A.P., Miller R.J., Bell G.I., and Polonsky K.S. A 48-hour exposure of pancreatic islets to calpain inhibitors impairs mitochondrial fuel metabolism and the exocytosis of insulin. Metabolism 52 (2003) 528-534
11. Sreenan S.K., Zhou Y.P., Otani K., Hansen P.A., Currie K.P., Pan C.Y., Lee J.P., Ostrega D.M., Pugh W., Horikawa Y., Cox N.J., Hanis C.L., Burant C.F., Fox A.P., Bell G.I., and Polonsky K.S. Calpains play a role in insulin secretion and action. Diabetes 50 (2001) 2013-2020
12. Parnaud G., Hammar E., Rouiller D.G., and Bosco D. Inhibition of calpain blocks pancreatic beta-cell spreading and insulin secretion. Am. J. Physiol. Endocrinol. Metab. 289 (2005) E313-E321
13. Paul D.S., Harmon A.W., Winston C.P., and Patel Y.M. Calpain facilitates GLUT4 vesicle translocation during insulin-stimulated glucose uptake in adipocytes. Biochem. J. 376 (2003) 625-632
14. Logie L.J., Brown A.E., Yeaman S.J., and Walker M. Calpain inhibition and insulin action in cultured human muscle cells. Mol. Genet. Metab. 85 (2005) 54-60
15. Baier L.J., Permana P.A., Yang X., Pratley R.E., Hanson R.L., Shen G.Q., Mott D., Knowler W.C., Cox N.J., Horikawa Y., Oda N., Bell G.I., and Bogardus C. A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance. J. Clin. Invest. 106 (2000) R69-R73
16. Carlsson E., Poulsen P., Storgaard H., Almgren P., Ling C., Jensen C.B., Madsbad S., Groop L., Vaag A., and Ridderstrale M. Genetic and nongenetic regulation of CAPN10 mRNA expression in skeletal muscle. Diabetes 54 (2005) 3015-3020
17. Kawano K., Hirashima T., Mori S., Saitoh Y., Kurosumi M., and Natori T. Spontaneous long-term hyperglycemic rat with diabetic complications Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes 41 (1992) 1422-1428
18. Kawano K., Hirashima T., Mori S., and Natori T. OLETF (Otsuka Long-Evans Tokushima Fatty) rat: a new NIDDM rat strain. Diabetes Res. Clin. Pract. 24 (1994) S317-S320 Suppl
19. Muramatsu Y., Taniguchi Y., Kose H., Matsumoto K., Yamada T., and Sasaki Y. Capn10, a candidate gene responsible for type 2 diabetes mellitus in the OLETF rat. IUBMB Life 55 (2003) 533-537
20. Iida S., Sato Y., Nakaya A., Shinohara Y., Hayashi Y., Sawada A., Nagata H., Kaji N., Kamiya H., Baba Y., and Harashima H. Genome wide expression analysis of white blood cells and liver of pre-diabetic Otsuka Long-Evans Tokushima Fatty (OLETF) rats using a cDNA microarray. Biol. Pharm. Bull. 29 (2006) 2451-2459
21. Sato Y., Kuwajima M., Kamiya H., and Harashima H. Calpain 10 as a predictive gene for type 2 diabetes: evidence from a novel screening system using white blood cells of Otsuka Long-Evans Tokushima Fatty (OLETF) rats. Biol. Pharm. Bull. 26 (2003) 1765-1768
22. Valera Mora M.E., Scarfone A., Calvani M., Greco A.V., and Mingrone G. Insulin clearance in obesity. J. Am. Coll. Nutr. 22 (2003) 487-493
23. Sesti G., D'Alfonso R., Vargas Punti M.D., Tullio A.N., Liu Y.Y., Federici M., Borboni P., Marini M.A., Lauro R., and Fusco A. Delayed intracellular dissociation of the insulin-receptor complex impairs receptor recycling and insulin processing in cultured Epstein-Barr virus-transformed lymphocytes from insulin-resistant subjects. Diabetologia 39 (1996) 289-295
24. McElduff A., Hedo J.A., Taylor S.I., Roth J., and Gorden P. Insulin receptor degradation is accelerated in cultured lymphocytes from patients with genetic syndromes of extreme insulin resistance. J. Clin. Invest. 74 (1984) 1366-1374
25. Taylor S.I., Samuels B., Roth J., Kasuga M., Hedo J.A., Gorden P., Brasel D.E., Pokora T., and Engel R.R. Decreased insulin binding in cultured lymphocytes from two patients with extreme insulin resistance. J. Clin. Endocrinol. Metab. 54 (1982) 919-930
26. Morii T., Ohno Y., Hirose H., Kawabe H., Ogata T., Hirao K., Eguchi T., Maruyama T., Kanno Y., Hayashi M., Saito I., and Saruta T. Cellular insulin resistance in Epstein-Barr virus-transformed lymphoblasts from young insulin-resistant Japanese men. Metabolism 54 (2005) 370-375
27. Rosser B.G., Powers S.P., and Gores G.J. Calpain activity increases in hepatocytes following addition of ATP. Demonstration by a novel fluorescent approach. J. Biol. Chem. 268 (1993) 23593-23600
28. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(- Delta Delta C(T)) Method. Methods 25 (2001) 402-408
29. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29 (2001) e45
30. Salazar A.M., Ostrosky-Wegman P., Menendez D., Miranda E., Garcia-Carranca A., and Rojas E. Induction of p53 protein expression by sodium arsenite. Mutat. Res. 381 (1997) 259-265
31. Deshpande R.V., Goust J.M., and Banik N.L. Differential distribution of calpain in human lymphoid cells. Neurochem. Res. 18 (1993) 767-773
32. Karlsson J.O., Blennow K., Janson I., Blomgren K., Karlsson I., Regland B., Wallin A., and Gottfries C.G. Increased proteolytic activity in lymphocytes from patients with early onset Alzheimer's disease. Neurobiol. Aging 16 (1995) 901-906
33. Fu Y., Maianu L., Melbert B.R., and Garvey W.T. Facilitative glucose transporter gene expression in human lymphocytes, monocytes, and macrophages: a role for GLUT isoforms 1, 3, and 5 in the immune response and foam cell formation. Blood Cells Mol. Diseases 32 (2004) 182-190
34. Doege H., Bocianski A., Joost H.G., and Schurmann A. Activity and genomic organization of human glucose transporter 9 (GLUT9), a novel member of the family of sugar-transport facilitators predominantly expressed in brain and leucocytes. Biochem. J. 3 (2000) 771-776
35. Maratou E., Dimitriadis G., Kollias A., Boutati E., Lambadiari V., Mitrou P., and Raptis S.A. Glucose transporter expression on the plasma membrane of resting and activated white blood cells. Eur. J. Clin. Investig. 37 (2007) 282-290
36. Curto M., Novi R.F., Rabbone I., Maurino M., Piccinini M., Mioletti S., Mostert M., Bruno R., and Rinaudo M.T. Insulin resistance in obese subjects and newly diagnosed NIDDM patients and derangements of pyruvate dehydrogenase in their circulating lymphocytes. Int. J. Obes. Relat. Metab. Disord. 21 (1997) 1137-1142
37. Piccinini M., Mostert M., Alberto G., Ramondetti C., Novi R.F., Dalmasso P., and Rinaudo M.T. Down-regulation of pyruvate dehydrogenase phosphatase in obese subjects is a defect that signals insulin resistance. Obes. Res. 13 (2005) 678-686
38. Timmers K.I., Dons R., Grunberger G., and Hodge J. Impaired 6-phosphofructokinase activity in mononuclear leukocytes from patients with type II diabetes mellitus. Enzyme 36 (1986) 247-253
39. Tu K.Y., Ju H.S., Pettit F., Shive W., Topek N.H., Matthews R., and Matthews K. Glycerol-3-phosphate dehydrogenase activity in human lymphocytes: effects of insulin, obesity and weight loss. Biochem. Biophys. Res. Commun. 207 (1995) 183-190
40. Hennige A.M., Stefan N., Kapp K., Lehmann R., Weigert C., Beck A., Moeschel K., Mushack J., Schleicher E., and Haring H.U. Leptin down-regulates insulin action through phosphorylation of serine-318 in insulin receptor substrate 1. FASEB J. 20 (2006) 1206-1208